R&D Centres

Our research team across our R&D centres comprises of several highly qualified scientists with expertise in formulation and analytical development and discovery of NCEs.

The Formulation R&D center based at Nashik, Maharashtra, India is spread over 40,000 sq. ft. and is engaged in the research of specialty and branded formulations for global markets. It has a dedicated facility that is engaged in the research of HFA based MDI products (Pressurized Metered Dose Inhalers). The center is equipped to research on a variety of dosage forms such as oral solid dosages, semi-solids, parenteral and aerosols for various indications. The center also is engaged in the research and development of Injections and Liposomal products.

Spread over 1,07,000 sq. ft. the R&D Centre in Taloja, on the outskirts of Mumbai, India is focused in identifying filing opportunities by doing effective product selection and patent landscaping with a vertical integration of API. The R&D unit works in co-ordination with the Intellectual Property Management team to develop cost effective and patent driven Generic Formulations that are bioequivalent to the original product but do not rely on any of the patents protecting the original formula.

Spread over 1,27,000 sq. ft, another R&D Center at Mahape on the outskirts of Mumbai, India has end-to-end capabilities for discovery and development of New Chemical Entities (NCEs) from target selection to clinical development. The research facility is equipped with modern infrastructure required to carry out research activities like Process & Analytical chemistry, Bulk Actives, Pharmacokinetics supported by Project Management, Clinical, Regulatory Affairs and IPM.

Biomedical waste annual returns 

Quality at Glenmark

Setting new benchmarks through delivery of high quality products across all geographies
Know More